Antonio Calles - Facultad de Ciencias, UNAM

基本信息

浏览量：15

职业迁徙

个人简介

Looking for new therapeutic opportunities for lung cancer patients, studying new targeted therapies and the mechanisms to overcome resistance, early drug development to translate those findings promptly to the clinic and developing new in vivo models for oncogenic-driven lung cancer and immunotherapeutics.

研究兴趣

论文共 205 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: the Phase I/II LUPER Study

Antonio Calles,Alejandro Navarro, Bernard Gaston Doger de Speville Uribe, Enric Álvarez Colomé,María de Miguel, Rosa Álvarez,Marta Arregui,Víctor Moreno, Pedro Rocha,Emiliano Calvo, Jorge Ramon-Patino,Elena Corral de la Fuente,Daniel Alcalá-López, Olga Boix, Melissa Fernández-Pinto,Jose Rodríguez-Morató,Ramón Palmero,Ernest Nadal,Maria Jove,Enriqueta Felip

Journal of thoracic oncology official publication of the International Association for the Study of Lung Cancer (2025)

引用0浏览0WOS引用

Efficacy and Safety of Lorlatinib in Patients with ALK- and ROS1-rearranged Metastatic Non-Small Cell Lung Cancer Treated Within the Compassionate Use Program in Spain

Antonio Calles, Mirian Alonso,Paloma Martín-Martorell, Ana Gómez,Javier de Castro, Maite Martínez-Aguillo,Anna Estival,Joaquin Mosquera, Natividad Martínez-Banaclocha,Margarita Majem,Roxana Reyes, Eider Azkona, Ana Laura Ortega, Santiago Aguin, Ana Santos, Andrés Aguilar, Marc Cucurull,Ana Blasco,Virginia Calvo,Dolores Isla,Ernest Nadal, Carlos Aguado,Elia Sais, Oscar Juan-Vidal, MPilar Diz-Taín,Álvaro Taus, Noemí Villanueva, Cristina Bayona, Margarita Amenedo,Xabier Mielgo, Esperanza Arriola, Javier Baena, Spanish Lung Cancer Group

Cancer treatment and research communications (2025): 100905-100905

引用0浏览0WOS引用

Preliminary Activity and Safety Results of KRAS G12C Inhibitor Glecirasib (JAB-21822) in Patients with Pancreatic Cancer and Other Solid Tumors